Average Co-Inventor Count = 6.57
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (45 from 3,684 patents)
2. Icagen, Inc. (3 from 101 patents)
45 patents:
1. 12168655 - Apelin receptor agonists and methods of use
2. 11390616 - Apelin receptor agonists and methods of use
3. 11008306 - Quinazolines as potassium ion channel inhibitors
4. 10889565 - 4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists
5. 10676460 - Quinazolines as potassium ion channel inhibitors
6. 10669261 - Heteroarylhydroxypyrimidinones as agonists of the APJ receptor
7. 10597370 - 2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors
8. 10590113 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
9. 10508104 - 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
10. 10392347 - 2,4-dihydroxy-nicotinamides as APJ agonists
11. 10214511 - Quinazolines as potassium ion channel inhibitors
12. 10173991 - Sulfone amide linked benzothiazole inhibitors of endothelial lipase
13. 10106528 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
14. 9822096 - Quinazolines as potassium ion channel inhibitors
15. 9493412 - Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors